Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)
China flag China · Delayed Price · Currency is CNY
53.09
-1.59 (-2.91%)
Apr 28, 2026, 3:04 PM CST

SHE:002294 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
60,95855,23934,48135,64436,22530,220
Market Cap Growth
66.30%60.20%-3.26%-1.60%19.87%3.71%
Enterprise Value
59,49453,22032,68833,89833,15427,017
Last Close Price
54.6849.5530.5331.6631.4125.63
PE Ratio
91.0784.7957.3261.4556.8656.62
Forward PE
77.0175.6551.5558.3254.7527.88
PS Ratio
13.4912.698.5910.5910.409.88
PB Ratio
6.586.103.944.434.543.76
P/TBV Ratio
8.047.564.685.335.244.38
P/FCF Ratio
1851.41705.1561.42211.6197.4243.02
P/OCF Ratio
57.0652.4929.0742.4637.3225.50
PEG Ratio
-1.031.031.031.031.03
EV/Sales Ratio
13.1712.238.1510.079.528.83
EV/EBITDA Ratio
55.1251.7331.2437.9537.9533.84
EV/EBIT Ratio
88.7383.1047.8059.9158.6253.57
EV/FCF Ratio
1806.93679.3758.22201.2489.1638.46
Debt / Equity Ratio
0.030.030.020.010.030.01
Debt / EBITDA Ratio
0.220.280.130.070.240.10
Debt / FCF Ratio
7.303.700.240.380.560.11
Net Debt / Equity Ratio
-0.17-0.31-0.31-0.27-0.42-0.40
Net Debt / EBITDA Ratio
-1.49-2.72-2.59-2.40-3.80-4.03
Net Debt / FCF Ratio
-48.17-35.75-4.83-12.70-8.93-4.58
Asset Turnover
0.410.400.400.350.370.38
Inventory Turnover
2.082.102.282.062.082.00
Quick Ratio
1.511.973.093.402.563.88
Current Ratio
2.342.283.624.072.944.35
Return on Equity (ROE)
7.41%7.33%7.20%7.25%7.92%7.75%
Return on Assets (ROA)
3.80%3.68%4.30%3.69%3.72%3.90%
Return on Invested Capital (ROIC)
9.51%10.37%10.95%9.69%10.60%9.13%
Return on Capital Employed (ROCE)
7.00%6.90%7.30%6.60%6.90%6.10%
Earnings Yield
1.11%1.18%1.75%1.63%1.76%1.77%
FCF Yield
0.05%0.14%1.63%0.47%1.03%2.33%
Dividend Yield
0.99%1.11%1.64%1.58%1.59%1.56%
Payout Ratio
82.75%85.68%90.77%94.71%69.25%2.91%
Buyback Yield / Dilution
-1.13%-0.83%0.13%-1.55%-2.90%-5.23%
Total Shareholder Return
-0.13%0.28%1.77%0.02%-1.31%-3.67%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.